Efficacy of EPs 7630 compared to N-acetylcysteine (ACC) in children with acute bronchitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN58336458

Enrollment

215

Registered

2003-03-26

Start date

2003-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute bronchitis Respiratory Bronchitis

Interventions

215 Children were randomised to receive either: 1. Herbal remedy EPs 7630, 20 drops three times daily 2. ACC, 200 mg twice daily The duration of individual treatment lasted over a maximum of 7 days.

Eligibility

Inclusion criteria

Inclusion criteria: Patients who met the following inclusion criteria were suitable for the trial: 1. Age 6 - 12 years, acute bronchitis, duration of complaints less than 48 hours and total score of bronchitis-specific symptoms greater than or equal to 5 points 2. In addition legal guardians had to sign an informed consent

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026